NCT03311347

Brief Summary

The primary aim of this project is to get further knowledge of the physiology of flight atelectasis and its prevention. We seek to: 1) assess whether low levels of positive pressure breathing can prevent atelectasis formation in humans during exposure to hyperoxia and +Gz-accelerations. 2) get further knowledge on the effects of hypobaria on regional ventilation and perfusion. A secondary aim is to evaluate the effect of anti G-trouser inflation on ventilation and regional perfusion.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 14, 2015

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

April 5, 2017

Completed
7 months until next milestone

First Posted

Study publicly available on registry

October 17, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

May 14, 2019

Status Verified

May 1, 2019

Enrollment Period

3.8 years

First QC Date

April 5, 2017

Last Update Submit

May 13, 2019

Conditions

Keywords

pulmonary ultrasoundhypergravityhuman physiologyoxygenlung ventilationlung perfusioncomputed tomographyelectrical impedance tomographyaltitude chamber

Outcome Measures

Primary Outcomes (3)

  • atelectasis formation (change between pre and post-protocol)

    computerized tomography: 0-5 scale for size and localization

    pre-protocol (baseline) and 1h30 min after centrifuge stop

  • change in pulmonary ventilation between 1 Gz, 1.6 Gz and 3.5 Gz

    electrical impedance tomography: deltaZ on regions of interest

    pre-protocol (baseline), baseline + 1hr, baseline +1h10 min, baseline +1h15 min

  • change in pulmonary tissue density from baseline at centrifuge stop and 1h30 min after stop

    ultrasound: number of lung comets + localization

    pre protocol (baseline), at centrifuge stop (baseline + 1h15 min) and 1h30 min after centrifuge stop

Study Arms (2)

100%O2 breathing

EXPERIMENTAL

Primary aim, item 1

Other: +Gz accelerations and positive pressure breathing

Air breathing

EXPERIMENTAL

Primary aim, item 1

Other: +Gz accelerations and positive pressure breathing

Interventions

100%O2 breathingAir breathing

Eligibility Criteria

Age25 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • normal lung function checked by pulmonary function tests.
  • normal ECG
  • normal clinical examination

You may not qualify if:

  • smoking
  • myopia
  • past medical history of heart or lung disease
  • current medical treatment for heart or lung disease
  • past medical history of back pain or spine trauma or disease
  • otitis
  • bad tolerance to +Gz accelerations (G-induced loss of consciousness, motion sickness)
  • claustrophobia in the centrifuge gondola
  • smoking
  • past medical history of heart or lung disease
  • current medical treatment for heart or lung disease
  • otitis
  • bad tolerance to the altitude chamber (15,000 ft): ear pain, claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Armed Forces Biomedical Research Institute

Brétigny-sur-Orge, 91 223, France

RECRUITING

Department of Radiology, Percy hospital

Clamart, 92140, France

ACTIVE NOT RECRUITING

Related Publications (2)

  • Dussault C, Gontier E, Verret C, Soret M, Boussuges A, Hedenstierna G, Montmerle-Borgdorff S. Hyperoxia and hypergravity are independent risk factors of atelectasis in healthy sitting humans: a pulmonary ultrasound and SPECT/CT study. J Appl Physiol (1985). 2016 Jul 1;121(1):66-77. doi: 10.1152/japplphysiol.00085.2016. Epub 2016 Apr 21.

    PMID: 27103651BACKGROUND
  • Borges JB, Hedenstierna G, Bergman JS, Amato MB, Avenel J, Montmerle-Borgdorff S. First-time imaging of effects of inspired oxygen concentration on regional lung volumes and breathing pattern during hypergravity. Eur J Appl Physiol. 2015 Feb;115(2):353-63. doi: 10.1007/s00421-014-3020-9. Epub 2014 Oct 17.

MeSH Terms

Conditions

Pulmonary Atelectasis

Interventions

Intermittent Positive-Pressure Ventilation

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Dominique Felten, MD

    Armed Forces Biomedical Research Institute

    STUDY CHAIR

Central Study Contacts

Stephanie S Montmerle-Borgdorff, MD, PhD

CONTACT

Catherine Verret, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Two arms are studied, breathing air or 100%O2. In each arm, subjects are studied at two occasions: with and without positive pressure breathing. These occasions are randomized.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2017

First Posted

October 17, 2017

Study Start

September 14, 2015

Primary Completion

June 30, 2019

Study Completion

January 1, 2020

Last Updated

May 14, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations